Compare SRL & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRL | MBOT |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.5M | 114.9M |
| IPO Year | 1996 | 2000 |
| Metric | SRL | MBOT |
|---|---|---|
| Price | $6.13 | $1.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 303.0 | ★ 1.8M |
| Earning Date | 05-12-2026 | 05-15-2026 |
| Dividend Yield | ★ 16.07% | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $119.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.13 | $1.60 |
| 52 Week High | $10.39 | $4.62 |
| Indicator | SRL | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 28.74 | 40.58 |
| Support Level | $5.37 | $1.65 |
| Resistance Level | $6.44 | $2.21 |
| Average True Range (ATR) | 0.35 | 0.12 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 48.57 | 16.13 |
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.